≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

ILD medications: acetylcysteine

Endpoint Browser

ILD_ASETYLCYSTEINE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — R05CB01

1 out of 7 registries used, show all original rules.

367

4. Check minimum number of events

Min. number of events 3
367

5. Include endpoints

None

367

6. Filter based on genotype QC (FinnGen only)

358

Control definitions (FinnGen only)

Control exclude
ILD_MEDICATIONS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 358 153 205
Unadjusted period prevalence (%) 0.08 0.05 0.09
Median age at first event (years) 61.43 53.67 67.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
367
Matched controls
3670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R05CB01
ATC
acetylcysteine; inhalant, oral
+∞
307.7
367
28
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
19.1
190.0
222
273
R03AC12
ATC
salmeterol; inhalant
35.4
185.6
127
54
R03DA04
ATC
theophylline; systemic, rectal
16.3
143.5
150
149
R03BB01
ATC
ipratropium bromide; inhalant
16.8
133.3
132
119
H02AB06
ATC
prednisolone; systemic
10.5
109.5
260
692
H02AB07
ATC
prednisone; oral
13.2
106.4
120
130
R03BA05
ATC
fluticasone; inhalant
10.5
105.4
154
236
R03AK06
ATC
salmeterol and fluticasone; inhalant
10.7
103.1
144
208
R03AK03
ATC
[U] fenoterol and ipratropium bromide
11.3
102.8
134
177
J45.9
ICD-10 Finland
Asthma, unspecified
10.1
95.6
138
206
H02AB04
ATC
methylprednisolone; systemic
11.2
92.5
117
147
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
8.9
92.0
157
284
R03BA02
ATC
budesonide; inhalant
8.9
85.9
139
235
R03BA01
ATC
beclometasone; inhalant
8.8
77.9
122
197
J45.1
ICD-10 Finland
Nonallergic asthma
15.5
73.7
69
54
R03AC03
ATC
terbutaline; inhalant
8.2
64.2
102
165
R03DC03
ATC
montelukast; oral
8.8
62.3
90
130
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
18.5
60.1
50
31
R03AC13
ATC
formoterol; inhalant
12.0
57.1
62
61
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
9.5
56.6
75
97
J45.0
ICD-10 Finland
Predominantly allergic asthma
14.2
55.0
53
43
R03BB04
ATC
tiotropium bromide; inhalant
7.0
53.9
99
185
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
15.6
53.8
49
36
R03AC02
ATC
salbutamol; inhalant
4.9
48.8
242
1033
J01FA06
ATC
roxithromycin; oral
3.8
35.0
202
898
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
52.8
32.2
38
8
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
7.2
31.7
51
81
J01AA02
ATC
doxycycline; systemic
5.6
31.0
322
2056
R05CB02
ATC
bromhexine; systemic
10.4
30.2
35
37
J46
ICD-10 Finland
Status asthmaticus
44.1
29.6
36
9
J96.1
ICD-10 Finland
Chronic respiratory failure
12.0
28.8
30
27
R03DC01
ATC
zafirlukast; oral
27.3
27.2
37
15
R03AK07
ATC
formoterol and budesonide; inhalant
4.5
26.9
77
206
R01AD08
ATC
fluticasone; nasal
3.6
25.7
109
384
J45
ICD-10 Finland
Asthma
5.6
20.8
42
83
J01FA10
ATC
azithromycin; systemic
2.8
20.5
177
920
J01FA09
ATC
clarithromycin; systemic
3.1
20.3
110
444
R05CB03
ATC
carbocisteine; oral
7.3
20.3
31
46
J45.8
ICD-10 Finland
Mixed asthma
24.2
19.4
27
12
J01DA06
ATC
[U] cefuroxime
3.6
19.0
72
232
A01AB09
ATC
miconazole; local oral
3.9
18.9
62
181
A01AB10
ATC
natamycin; local oral
6.9
18.2
29
45
J47
ICD-10 Finland
Bronchiectasis
17.7
18.2
28
17
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.3
18.0
80
285
R05FB02
ATC
cough suppressants and expectorants; systemic
2.6
17.6
187
1055
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
17.5
163
863
A01AB04
ATC
amphotericin B; local oral
4.8
17.3
41
93
R06AE07
ATC
cetirizine; oral
2.6
17.2
144
722
J01MA14
ATC
moxifloxacin; systemic
4.3
17.2
48
124
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
52.7
17.2
20
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.0
17.1
92
366
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.7
16.2
57
174
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
16.2
47
125
J01DA01
ATC
[U] cefalexin
2.6
16.0
248
1643
49300
ICD-8 Finland
Asthma, bronchiale
12.0
15.5
28
25
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.5
15.1
30
58
J01FA01
ATC
erythromycin; systemic
3.5
14.1
54
174
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
14.1
99
450
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
21.1
13.9
20
10
L01BA01
ATC
methotrexate; systemic
78.1
13.7
15
*
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.5
13.4
107
515
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
13.4
157
898
R96
ICPC
Asthma
4.4
13.3
35
86
J01FA15
ATC
telithromycin; oral
4.2
13.3
37
95
A02BA04
ATC
nizatidine; systemic
3.3
12.9
54
184
R03BB02
ATC
oxitropium bromide; inhalant
16.2
12.8
20
13
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
16.2
12.8
20
13
A02BA02
ATC
ranitidine; systemic
2.4
12.7
112
563
A07AA02
ATC
nystatin; oral
4.0
12.6
37
99
J01DA08
ATC
[U] cefaclor
4.0
12.4
37
100
M05BA04
ATC
alendronic acid; oral
3.3
12.4
51
172
N05BA01
ATC
diazepam; systemic, rectal
2.8
11.8
66
265
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
67.2
11.7
13
*
J02AC01
ATC
fluconazole; systemic
2.3
11.6
124
675
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
12.4
11.5
20
17
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.8
11.2
35
98
R05DB05
ATC
pentoxyverine; oral, rectal
4.9
11.1
25
54
C03CA01
ATC
furosemide; systemic
2.1
11.1
191
1246
R03BC03
ATC
nedocromil; inhalant
3.7
10.6
35
102
R06AX12
ATC
terfenadine; oral
5.1
10.4
22
45
N02AC04
ATC
dextropropoxyphene; oral
3.6
10.3
36
109
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
9.5
10.1
20
22
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
3.3
10.1
39
126
C01AA05
ATC
digoxin; systemic
2.4
9.9
85
417
J01DA09
ATC
[U] cefadroxil
2.2
9.9
104
556
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.1
9.9
21
43
J01MA12
ATC
levofloxacin; systemic
2.4
9.8
83
405
R05FA02
ATC
opium derivatives and expectorants; systemic
2.0
9.5
147
908
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.4
9.5
20
25
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
30.9
9.5
12
*
R01AD05
ATC
budesonide; nasal
3.5
9.0
32
98
C08DA01
ATC
verapamil; systemic
3.4
8.9
33
104
N06AB03
ATC
fluoxetine; oral
2.8
8.8
47
183
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.8
8.6
13
8
R03DA05
ATC
aminophylline; systemic, rectal
10.4
8.6
16
16
51899
ICD-8 Finland
Bronchiectasis
28.3
8.5
11
*
R06AX13
ATC
loratadine; oral
2.8
8.5
45
175
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
92.1
8.4
9
*
R03AK11
ATC
formoterol and fluticasone; inhalant
13.2
8.4
14
11
N05CF01
ATC
zopiclone; oral
1.9
8.3
152
986
R01AD01
ATC
beclometasone; nasal
2.6
8.1
52
223
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.3
8.0
30
95
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.0
7.8
22
57
J01MA01
ATC
ofloxacin; systemic
2.5
7.8
52
227
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
7.8
151
994
M01CB01
ATC
sodium aurothiomalate; parenteral
46.0
7.7
9
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.0
7.7
109
645
L04AX03
ATC
methotrexate; systemic
18.8
7.6
11
6
A98
ICPC
Health maint/preventive medicine
0.5
7.6
164
2198
R01AD09
ATC
mometasone; nasal
2.0
7.6
113
680
A02BA03
ATC
famotidine; systemic
3.3
7.6
29
93
A02BC01
ATC
omeprazole; systemic
1.9
7.6
115
697
G47.3
ICD-10 Finland
Sleep apnoea
2.4
7.5
55
250
A12BA01
ATC
potassium chloride; oral
2.6
7.3
44
183
N05CD07
ATC
temazepam; oral
2.1
7.2
81
439
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.3
7.1
13
13
P01BA02
ATC
hydroxychloroquine; oral
4.5
7.0
17
39
R04.2
ICD-10 Finland
Haemoptysis
3.7
7.0
22
62
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.5
7.0
24
72
R06AE09
ATC
levocetirizine; oral
2.8
6.9
35
133
R05CA10
ATC
expectorants - combinations
4.4
6.8
17
40
A07EC01
ATC
sulfasalazine; oral, rectal
4.4
6.8
17
40
L04AX01
ATC
azathioprine; systemic
40.8
6.8
8
*
4224
FHL
Endonasal anthrostomy
12.6
6.6
11
9
J01DC02
ATC
cefuroxime; systemic
4.3
6.6
17
41
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
8.9
6.6
13
15
N06AA12
ATC
doxepin; systemic
2.9
6.5
32
119
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
6.4
99
598
C03DA01
ATC
spironolactone; oral
2.2
6.3
60
305
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
7.2
6.3
14
20
L04AA13
ATC
[U] leflunomide
+∞
6.3
6
*
A06AD11
ATC
lactulose; oral
1.9
6.3
96
579
A03FA02
ATC
cisapride; oral, rectal
2.4
6.2
44
197
R95
ICPC
Chron obstructive pulmonary disease
5.9
6.2
16
28
N05BB01
ATC
hydroxyzine; systemic
2.9
6.2
30
111
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.2
144
986
R06.2
ICD-10 Finland
Wheezing
4.2
6.1
16
39
R03AK08
ATC
formoterol and beclometasone; inhalant
6.9
6.1
14
21
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
6.9
6.1
14
21
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.7
6.1
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
11
24.27
18.00
4.8
1.5
—
—
—
0
0
170
2219
0.56
6.70
42.0
21.3
36.71
38.56
%
1.79
159
2029
148
1977
0.58
6.02
5.5
4.8
6.25
6.11
mmol/l
0.42
130
1738
25
87
3.01
5.74
4.2
1.6
9.93
10.10
g/l
0.08
25
70
103
1499
0.57
5.62
5.4
4.1
—
—
—
0
0
170
2164
0.60
5.42
32.9
18.2
4.01
4.01
mmol/l
0.09
165
2076
164
2103
0.60
5.35
27.9
14.4
—
—
—
0
0
169
2139
0.61
5.09
14.2
8.6
26.05
22.89
u/l
0.72
163
2026
44
215
2.19
5.08
4.7
3.4
5.77
5.78
kpa
0.02
44
204
21
72
3.03
4.96
2.3
1.5
1.33
1.75
g/l
0.35
21
56
26
102
2.67
4.83
2.0
1.4
—
—
—
0
0
13
26
5.14
4.67
4.8
2.9
—
—
—
0
0
155
1979
0.62
4.62
5.2
5.1
2.62
2.57
mmol/l
0.27
135
1757
38
186
2.16
4.38
4.1
2.6
4.09
3.99
kpa
0.11
38
176
40
205
2.07
4.11
2.8
1.3
—
—
—
0
0
27
118
2.39
4.05
3.7
2.8
25.00
25.08
mmol/l
0.04
27
113
149
1881
0.65
3.91
4.8
4.4
1.56
1.48
mmol/l
1.07
130
1671
152
1901
0.66
3.73
4.7
4.5
4.64
4.47
mmol/l
1.28
136
1708
145
1822
0.66
3.58
4.4
4.0
1.23
1.23
mmol/l
0.02
130
1599
169
2052
0.67
3.44
29.5
14.3
25.79
27.18
mg/l
0.20
148
1610
25
115
2.26
3.37
2.3
1.4
—
—
—
0
0
25
116
2.24
3.31
5.2
2.4
1.09
0.47
%
0.33
11
37
107
776
1.53
3.29
9.4
3.3
—
—
—
0
0
154
1892
0.68
3.25
7.6
6.2
42.05
41.23
mmol/mol
0.35
136
1717
14
49
2.93
3.22
3.1
2.5
—
—
—
0
0
20
85
2.43
3.21
3.3
2.6
—
—
—
0
0
40
228
1.85
3.06
2.5
1.7
—
—
—
0
0
23
109
2.18
2.91
5.1
2.4
0.00
0.26
%
—
8
31
40
232
1.81
2.90
10.8
5.1
1.87
1.38
mmol/l
0.28
33
178
24
116
2.14
2.90
5.3
2.4
0.00
0.11
%
—
10
37
155
1875
0.70
2.83
5.7
4.6
1.98
2.70
mu/l
0.53
139
1637
5
6
8.43
2.75
3.4
3.2
75.10
56.17
%
—
5
6
6
10
6.08
2.71
1.2
1.0
—
—
—
0
0
26
134
2.01
2.68
7.3
3.2
—
—
—
0
0
21
100
2.17
2.64
4.9
2.4
3.43
0.39
%
—
7
31
19
87
2.25
2.62
7.5
4.7
—
—
—
0
0
116
894
1.44
2.56
8.8
3.1
0.19
0.19
e9/l
0.00
110
762
113
868
1.44
2.54
8.3
3.0
0.04
0.04
e9/l
0.12
106
722
115
888
1.43
2.50
8.8
3.1
1.77
1.92
e9/l
0.45
108
768
112
863
1.43
2.46
8.4
3.0
0.67
0.58
e9/l
3.03
105
717
12
49
2.50
2.12
2.8
2.1
—
—
—
0
0
10
39
2.61
1.95
1.0
1.1
—
—
—
0
0
27
158
1.77
1.95
3.3
4.0
96.65
92.24
ng/l
0.07
22
137
41
270
1.58
1.92
10.9
5.0
104.32
104.43
mmol/l
0.04
41
270
28
167
1.73
1.90
13.3
5.9
—
—
—
0
0
6
18
3.37
1.75
1.3
1.8
—
—
—
0
0
6
18
3.37
1.75
1.0
1.2
—
—
—
0
0
7
24
2.95
1.73
2.3
1.8
4.91
5.04
e9/l
—
7
24
11
49
2.28
1.65
1.3
1.1
—
—
—
0
0
23
137
1.72
1.59
2.0
1.4
—
—
—
0
0
42
292
1.50
1.57
2.8
2.0
—
—
—
0
0
7
27
2.62
1.52
2.6
1.9
61.86
59.37
%
—
7
27
23
140
1.69
1.49
7.4
4.0
—
—
—
0
0
45
614
0.70
1.48
2.6
2.9
5.95
6.79
mmol/l
0.86
37
493
5
16
3.15
1.44
1.4
1.1
—
—
—
0
0
19
111
1.75
1.42
2.2
1.4
—
—
—
0
0
35
496
0.67
1.41
1.7
1.6
1.20
1.27
mmol/l
0.18
29
399
15
82
1.86
1.37
14.8
5.9
—
—
—
0
0
74
588
1.32
1.31
2.7
2.1
3.28
3.33
mg/l
0.05
62
497
18
107
1.72
1.28
2.3
1.3
—
—
—
0
0
16
263
0.59
1.25
1.9
1.3
—
—
—
0
0
37
498
0.71
1.14
4.1
3.0
2.49
2.46
mmol/l
0.57
31
423
19
119
1.63
1.14
15.9
6.3
0.77
0.72
%
0.18
19
119
8
40
2.02
1.12
2.0
1.7
29.38
34.85
umol/l
—
8
33
32
228
1.44
1.10
1.2
1.3
—
—
—
0
0
19
121
1.60
1.08
15.7
6.0
1.41
1.41
%
0.01
19
121
122
1057
1.23
1.07
11.2
6.3
4.83
4.10
e9/l
2.17
117
895
48
612
0.75
1.05
2.5
3.0
1550.23
155.21
mg/l
0.44
28
390
50
389
1.33
1.04
1.9
1.5
1.67
1.35
mg/l
0.22
40
307
131
1481
0.82
1.03
6.9
5.0
153.14
5423.85
e6/l
—
7
40
7
36
1.96
0.97
1.7
1.1
0.72
0.79
nmol/l
—
7
28
94
801
1.23
0.96
4.3
3.4
—
—
—
0
0
25
175
1.46
0.95
11.0
4.6
1.18
1.44
mmol/l
1.16
25
168
58
470
1.28
0.91
8.3
5.4
—
—
—
0
0
9
154
0.57
0.90
2.0
1.5
—
—
—
0
0
66
790
0.80
0.89
2.9
2.3
—
—
—
0
0
137
1524
0.84
0.88
4.5
3.8
15.27
15.05
pmol/l
0.39
121
1321
22
154
1.46
0.85
1.4
1.3
384.00
427.50
titre
—
5
32
6
32
1.89
0.82
6.8
2.4
—
—
—
0
0
6
32
1.89
0.82
2.5
1.7
62.42
55.46
%
—
6
32
78
667
1.22
0.78
5.9
3.7
—
—
—
0
0
58
693
0.81
0.77
6.5
4.0
—
—
—
0
0
9
54
1.68
0.75
1.9
1.6
—
—
—
0
0
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
9
56
1.62
0.73
2.7
3.5
—
—
—
0
0
131
1432
0.87
0.63
6.7
4.1
—
—
—
0
0
38
464
0.80
0.63
4.4
3.2
315.97
124.39
ng/l
0.28
32
394
92
816
1.17
0.62
5.9
3.8
6.20
5.82
ph
—
5
30
35
282
1.27
0.61
2.1
1.3
1.88
2.64
g/l
1.50
28
138
9
65
1.39
0.51
1.3
1.3
—
—
—
0
0
23
181
1.29
0.49
1.7
2.0
82.57
61.79
e9/l
1.31
15
141
57
651
0.85
0.49
2.8
3.6
9.40
8.71
mg/mmol
0.04
37
399
52
597
0.85
0.48
1.8
1.6
30.16
20.74
nmol/l
0.59
45
495
22
174
1.28
0.46
1.5
1.4
84.25
106.30
ug/g
0.31
16
132
0
16
0.00
0.41
0.0
1.3
—
67.60
—
0
10
14
182
0.76
0.40
5.0
4.1
—
—
—
0
0
15
193
0.77
0.40
1.5
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
10
71
1.42
0.39
8.4
3.5
3.72
3.96
mmol/l
—
10
71
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
153
1616
0.91
0.38
10.0
5.8
80.10
83.99
u/l
0.31
145
1467
72
654
1.13
0.36
3.2
2.1
—
—
—
0
0
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
24
199
1.22
0.36
2.4
2.8
151.87
216.68
ng/l
0.51
24
182
6
42
1.44
0.35
3.5
2.1
—
—
—
0
0
88
817
1.10
0.31
4.3
2.5
122.91
131.69
ug/l
0.19
82
724
31
355
0.86
0.30
1.4
1.2
1.87
1.29
u/ml
—
6
95
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
11
85
1.30
0.28
7.7
4.0
1.52
1.43
mmol/l
0.11
11
85
143
1497
0.93
0.27
6.7
2.8
16.03
14.73
mm/h
0.44
133
1318
75
807
0.91
0.27
5.5
3.7
104.91
222.83
e6/l
0.62
61
585
55
504
1.11
0.25
4.7
3.0
562.86
534.39
mosm/kgh2o
0.48
50
430
73
783
0.92
0.25
5.3
3.0
2.34
2.36
mmol/l
0.28
60
671
6
81
0.74
0.24
1.0
1.4
—
20.76
—
0
5
5
39
1.29
0.23
2.2
1.5
—
—
—
0
0
57
615
0.91
0.22
4.2
3.2
—
—
—
0
0
55
593
0.91
0.21
6.3
4.3
0.00
0.00
estimate
-0.00
12
169
97
1021
0.93
0.21
6.6
4.1
0.00
0.00
estimate
-0.00
17
206
0
11
0.00
0.21
0.0
1.5
—
14.78
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
8.29
—
0
10
8
101
0.79
0.21
1.6
3.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
67
715
0.92
0.21
4.7
3.3
35.96
181.65
e6/l
0.91
56
544
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
111
1161
0.94
0.20
15.5
18.7
1.23
1.39
inr
0.85
25
315
0
14
0.00
0.20
0.0
2.6
—
6.99
—
0
9
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
22
194
1.14
0.19
4.0
3.1
—
—
—
0
0
133
1283
1.06
0.18
8.2
3.9
7.00
6.90
mmol/l
0.18
127
1190
6
76
0.79
0.15
1.8
2.3
—
—
—
0
0
98
1018
0.95
0.14
10.3
5.5
0.00
0.00
estimate
-0.00
13
178
11
93
1.19
0.14
11.6
3.4
—
—
—
0
0
26
240
1.09
0.11
1.3
1.2
25.31
20.32
iu/ml
—
7
74
47
494
0.94
0.10
6.1
4.5
1.01
1.02
kg/l
—
7
76
100
1028
0.96
0.10
6.5
4.1
0.00
0.00
estimate
-0.00
13
175
37
351
1.06
0.09
2.7
1.5
28.60
29.66
s
0.63
37
341
83
854
0.96
0.08
15.1
8.5
0.00
0.00
e9/l
1.33
71
692
6
58
1.04
0.08
3.2
2.7
—
—
—
0
0
7
64
1.10
0.08
1.3
1.7
34.21
32.75
mg/l
—
7
51
7
64
1.10
0.08
1.3
1.7
29.43
154.30
mg/l
—
7
51
7
66
1.06
0.08
1.9
1.2
—
—
—
0
0
56
540
1.04
0.08
2.0
1.8
1211.98
1198.78
nmol/l
0.04
41
402
9
104
0.86
0.06
1.3
1.3
—
—
—
0
0
92
940
0.97
0.06
5.5
4.2
164.24
78.10
ng/l
0.30
75
733
42
436
0.96
0.06
1.1
1.3
—
—
—
0
0
23
217
1.06
0.06
1.2
1.2
1.16
2.25
u/ml
—
9
70
63
646
0.97
0.05
4.5
3.2
0.31
0.60
e6/l
1.14
53
484
67
686
0.97
0.05
5.8
3.3
7.40
7.40
ph
0.07
13
130
49
477
1.03
0.04
4.9
2.3
10319.73
10429.07
umol/l
0.00
44
392
12
129
0.93
0.03
1.2
1.1
—
—
—
0
0
13
139
0.93
0.03
1.7
1.5
—
—
—
0
0
98
968
1.02
0.03
2.2
2.1
99.84
94.53
pmol/l
0.42
45
476
12
128
0.94
0.02
3.7
2.5
—
—
—
0
0
58
570
1.02
0.02
7.9
3.8
—
—
—
0
0
10
107
0.93
0.02
1.6
1.3
—
—
—
0
0
55
558
0.98
0.01
3.1
3.3
—
—
—
0
0
54
534
1.01
0.00
2.0
1.8
498.84
450.67
pmol/l
0.52
43
422
36
359
1.00
0.00
4.2
3.1
4.26
2.95
e6/l
0.29
22
199
47
471
1.00
0.00
5.6
4.0
—
—
—
0
0
112
1116
1.01
0.00
11.4
4.8
1.22
1.22
mmol/l
0.03
96
916
100
1005
0.99
0.00
11.4
4.4
1.21
1.22
mmol/l
0.84
91
892
19
186
1.02
0.00
9.5
3.5
—
—
—
0
0
17
166
1.03
0.00
4.8
3.4
—
—
—
0
0
5
49
1.02
0.00
1.4
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
156.07
—
0
9
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
2.34
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
15
150
1.00
-0.00
1.6
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
16.42
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
2.14
—
0
8
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
60
1.00
-0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
53.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
70
1.00
-0.00
7.6
11.0
—
—
—
0
0
7
71
0.99
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
64
0.94
-0.00
4.8
3.7
—
—
—
0
0
6
66
0.91
-0.00
1.7
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
6.84
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_ASETYLCYSTEINE – ILD medications: acetylcysteine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).